NASDAQ: KTTA - Pasithea Therapeutics Corp.

Yield per half year: -75.28%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Pasithea Therapeutics Corp.

Extended chart Simple chart
Financial Markets by TradingView

About Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for Central Nervous System disorders, RASopathies, and other diseases. It operates through two segments, Therapeutics and Clinics. The company provides business support services to anti-depression clinics, entities, and registered healthcare providers.

more details
Its lead product candidate PAS-004, a next-generation mitogen-activated protein kinase, or MEK inhibitor designed to be macrocyclic for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 and Noonan syndrome, as well as lamin A/C cardiomyopathy and oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; PAS-002, for the treatment multiple sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-09-15
ISIN US70261F1030
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.pasithea.com
Цена ао 1.38
Change price per day: +1.52% (1.32)
Change price per week: +8.06% (1.24)
Change price per month: +3.88% (1.29)
Change price per 3 month: -50.92% (2.73)
Change price per half year: -75.28% (5.42)
Change price per year: -81.52% (7.2503)
Change price per 3 year: -0.7407% (1.35)
Change price per year to date: -49.62% (2.66)
All parameters

Underestimation

Title Value Grade
P/S 21.83 1
P/BV 0.454 10
P/E 0 0
EV/EBITDA 0.367 10
Total: 5.13

Efficiency

Title Value Grade
ROA, % -61.12 0
ROE, % -68.22 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0053 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 3143.73 10
Yield Ebitda, % 37292.46 10
Yield EPS, % 21770.47 10
Total: 10
More

Institutions Volume Share, %
Geode Capital Management, LLC 6256 0.6
Northern Trust Corporation 2354 0.23
Renaissance Technologies, LLC 1625 0.16
JANE STREET GROUP, LLC 1179 0.11
Tower Research Capital LLC (TRC) 620 0.06
Royal Bank of Canada 250 0.02
JP Morgan Chase & Company 150 0.01
Wells Fargo & Company 6 0



Head Job title Payment Year of birth
Dr. Lawrence Steinman BA, M.D., Ph.D. Co-Founder, MD & Executive Chairman 250k 1948 (77 years)
Dr. Tiago Reis Marques M.D., Ph.D. CEO & Director 480k 1977 (48 years)
Mr. Daniel H. Schneiderman Chief Financial Officer 345.94k 1978 (47 years)
Dr. Yassine Bendiabdallah Ph.D. COO & Head of UK Clinics N/A 1984 (41 year)
Dr. Graeme Currie Ph.D. Chief Development Officer 346.62k 1967 (58 years)

Address: United States, Miami Beach. FL, 1111 Lincoln Road - open in Google maps, open in Yandex maps
Website: https://www.pasithea.com